Chemoinformaics analysis of 1-ETHENYL-1,4-BIS(4-METHYLPENT-3-ENYL)CYCLOHEXANE
| Molecular Weight | 274.492 | nRot | 7 |
| Heavy Atom Molecular Weight | 240.22 | nRig | 18 |
| Exact Molecular Weight | 274.266 | nRing | 1 |
| Solubility: LogS | -3.869 | nHRing | 0 |
| Solubility: LogP | 3.099 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 56.071 |
| nHD | 0 | BPOL | 34.109 |
| QED | 0.677 |
| Synth | 2.441 |
| Natural Product Likeliness | 1.456 |
| NR-PPAR-gamma | 0.953 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.996 |
| Pgp-sub | 0.001 |
| HIA | 0.023 |
| CACO-2 | -4.996 |
| MDCK | 0.000014 |
| BBB | 0.005 |
| PPB | 0.933062 |
| VDSS | 0.714 |
| FU | 0.108145 |
| CYP1A2-inh | 0.942 |
| CYP1A2-sub | 0.887 |
| CYP2c19-inh | 0.334 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.769 |
| CYP2c9-sub | 0.85 |
| CYP2d6-inh | 0.435 |
| CYP2d6-sub | 0.324 |
| CYP3a4-inh | 0.365 |
| CYP3a4-sub | 0.144 |
| CL | 4.513 |
| T12 | 0.798 |
| hERG | 0.019 |
| Ames | 0.704 |
| ROA | 0.152 |
| SkinSen | 0.626 |
| Carcinogencity | 0.126 |
| EI | 0.828 |
| Respiratory | 0.171 |
| NR-Aromatase | 0.926 |
| Antiviral | Yes |
| Prediction | 0.730137 |